Rohan Pharma Private Limited, a active private limited company, was established on 20 December 1996 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231DL1996PTC083978. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.46 Cr.
It upholds a compliant status. Its leadership includes Ankita Sardana (Director), Anita Sardana (Director), Gireesh Sardana (Whole-Time Director). It holds ₹11.54 Cr open charges and ₹3.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 315/274, Ground Floor (Left Hand Side), Westend Marg, Saidulajab, Near Saket Metro Station,, New Delhi, Delhi, 110030.
U24231DL1996PTC083978
083978
20 December 1996
₹1.50 Cr
₹1.46 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rohan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankita Sardana | Director | 27 Jul 2021 | Current |
| Anita Sardana | Director | 20 Dec 1996 | Current |
| Gireesh Sardana | Whole-Time Director | 20 Dec 1996 | Current |
| Rohan Sardana | Whole-Time Director | 21 Dec 1996 | Current |
| Aryavir Sardana | Additional Director | 17 Jan 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rohan Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.52% decrease. The company also saw a substantial fall in profitability, with a 76.17% decrease in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2022, Rohan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹115,400,000.00
₹34,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2020 | Axis Bank Limited | ₹5.40 M | Open |
| 10 Dec 2019 | Axis Bank Limited | ₹11.00 Cr | Open |
| 30 Mar 2023 | Others | ₹7.50 M | Satisfied |
| 25 Apr 2019 | Others | ₹2.25 Cr | Satisfied |
| 09 Mar 2007 | State Bank Of Travencore | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rohan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rohan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rohan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aryavir Sardana was appointed as a Additional Director was appointed as a Additional Director on 17 Jan 2025 & has been associated with this company since 11 months 8 days . was documented.
Progress on Rohan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Axis Bank Limited of Rs. 11.00 Cr registered on 10 Dec 2019 with Charge ID 100311379 was modified on 24 Sep 2024. was recorded as a recent event.
Rohan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on A charge registered on 30 Mar 2023 via Charge ID 100707855 with Others was fully satisfied on 03 Nov 2023. was documented.
The activity A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100707855 was registered on 30 Mar 2023. was completed.
The CIN of Rohan Pharma Private Limited is U24231DL1996PTC083978.
Rohan Pharma Private Limited is headquartered at 315/274, Ground Floor (Left Hand Side), Westend Marg, Saidulajab, Near Saket Metro Station,, New Delhi, Delhi, 110030.
Rohan Pharma Private Limited was incorporated on 20 December 1996.
The current directors of Rohan Pharma Private Limited are
The primary industry of Rohan Pharma Private Limited is Trade.
Rohan Pharma Private Limited is unlisted.
The authorized capital of Rohan Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.46 Cr.
The compliance status of Rohan Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX